Compounds > trihexyphenidyl
Page last updated: 2024-11-05

trihexyphenidyl and Dermatitis Medicamentosa

trihexyphenidyl has been researched along with Dermatitis Medicamentosa in 1 studies

Trihexyphenidyl: One of the centrally acting MUSCARINIC ANTAGONISTS used for treatment of PARKINSONIAN DISORDERS and drug-induced extrapyramidal movement disorders and as an antispasmodic.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Schmutz, JL1
Barbaud, A1
Tréchot, P1

Other Studies

1 other study available for trihexyphenidyl and Dermatitis Medicamentosa

ArticleYear
[Polymorphous bullous erythema and trihexiphenidyl (or why police questioning is not always the most productive method)].
    Annales de dermatologie et de venereologie, 2007, Volume: 134, Issue:11

    Topics: Adult; Antiparkinson Agents; Drug Eruptions; Erythema; Humans; Male; Skin Diseases, Vesiculobullous;

2007